Ozempic Statistics And Trends in 2024
Last updated: January 2024
Ozempic, developed by Novo Nordisk, was approved for use in the United States in 2017.
Initially, its primary purpose was for the treatment of type 2 diabetes. However, its potential as an anti-obesity medication for long-term weight management soon became evident. Its effectiveness and growing popularity led it to being featured in more than 30 000 news outlets worldwide.
Despite its relatively recent introduction, Ozempic generated over $6 billion in sales in the United States in 2022 alone, underscoring its rapid acceptance in the medical community.
From its global sales to its impact on Novo Nordisk's stock price and its prominence in the mainstream media, here’s a breakdown of everything you’ll find out on this page:
Key Ozempic Stats
Ozempic Sales
Ozempic Sales & Revenue
Ozempic Prescriptions for Non-diabetic Adults
Novo Nordisk Sales & Revenue
Novo Nordisk Bestselling Products in 2022
Novo Nordisk Stock Price
Ozempic Price for One-month Supply
Ozempic Mainstream Interest
Ozempic Google Search Interest
Ozempic News Articles
Ozempic TikTok Videos
Ozempic Instagram Posts
Ozempic Podcasts Episodes
Weight Loss Drugs Market
Weight Loss Drugs U.S. Market Size
Weight Loss Drugs Google Search Interest
Weight Loss Drugs News Articles
Obesity in the U.S.
Key Ozempic Stats
Ozempic recorded sales of $8.5 billion in 2022, with 65% of sales in the U.S.
In 2023, Novo Nordisk reported $28.4B in sales, with Ozempic contributing to 40% of that figure.
Ozempic has been mentioned in 148,800 news articles since 2021.
Tiktok videos about Ozempic have got a total of 1.2 billion views since 2021.
Ozempic is the most searched weight loss drug, outpacing Wegovy, its closest competitor, by 300%.
Ozempic Sales
Ozempic, the prominent drug by Novo Nordisk, has witnessed a significant trajectory in the pharmaceutical landscape. The upward trend in Ozempic's sales underscores its growing prominence within Novo Nordisk's product range and reflects overarching patterns observed in the sector.
Ozempic Sales & Revenue
In 2022, total sales of Ozempic reached $8.5 billion, of which the U.S. accounted for 65%. Ozempic is projected to maintain its sales momentum over the next five years, anticipated to reach an annual sales milestone of $12.5 billion in 2023 and $17 billion by 2029.
We’ve charted Ozempic’s annual forecasted sales in $US billion from 2022 to 2029:
| Years | Europe | United States | Rest of World |
|---|---|---|---|
| 2022 | 1.7 | 6 | 1.8 |
| 2023 | 2.7 | 7.0 | 2.8 |
| 2024 | 3.0 | 7.5 | 3.0 |
| 2025 | 3.3 | 8.0 | 3.2 |
| 2026 | 3.6 | 8.5 | 3.4 |
| 2027 | 3.9 | 9.0 | 3.6 |
| 2028 | 4.2 | 9.5 | 3.8 |
| 2029 | 4.5 | 10.0 | 4.0 |
Source: GlobalData, Drugs Database
Novo Nordisk Sales & Revenue
Over 15 years, from 2009 to 2023, Novo Nordisk (the maker of Ozempic) net sales have almost quadrupled, growing from $7.2 billion to $28.3 billion, resulting in a total of $246.9 billion in net sales. The largest year-over-year growth occurred between 2021 and 2022, with sales surging by approximately $5.1 billion, a growth rate of nearly 25.6%.
Here’s a table showing the growth in Novo Nordisk's sales in USD since 2009:
| Years | Sales |
|---|---|
| 2009 | $7.1 billion |
| 2010 | $8.5 billion |
| 2011 | $9.3 billion |
| 2012 | $10.9 billion |
| 2013 | $11.7 billion |
| 2014 | $12.4 billion |
| 2015 | $15.1 billion |
| 2016 | $15.7 billion |
| 2017 | $15.6 billion |
| 2018 | $17.1 billion |
| 2019 | $17.6 billion |
| 2020 | $17.8 billion |
| 2021 | $19.7 billion |
| 2022 | $24.8 billion |
| 2023 | $28.4 billion |
Source: Statista
Ozempic Prescriptions for Non-Diabetic Adults
The total prescriptions for Ozempic in 2022 reached 2.2M, marking a staggering 857% growth since 2019. Approximately one-quarter of all Ozempic prescriptions were issued for individuals not diagnosed with diabetes even though the drug is not yet officially approved for weight loss.
Here’s a table that contains the full prescriptions data:
| Years | Prescriptions |
|---|---|
| 2019 | 230,000 |
| 2020 | 510,000 |
| 2021 | 1,200,000 |
| 2022 | 2,200,000 |
Source: Komodo Health
Novo Nordisk Bestselling Products in 2022
Ozempic, with $8.3 billion in sales, is the leading Novo Nordisk product, accounting for 38.3% of the company’s total sales in 2022. The difference in sales between Ozempic and the second-highest selling product, NovoRapid, is a substantial $6.2 billion, with Ozempic sales being 118% higher.
Here’s the list of the top 10 Novo Nordisk products by sales in USD in 2022:
| Drugs | Sales |
|---|---|
| Ozempic | $8.4 billion |
| NovoRapid | $2.2 billion |
| Victoza | $1.7 billion |
| Rybelsus | $1.59 billion |
| Saxenda | $1.5 billion |
| Tresiba | $1.3 billion |
| NovoSeven | $1.2 billion |
| Human insulin | $1.1 billion |
| NovoMix | $1.1 billion |
| Levemir | $0.6 billion |
Source: Statista
Ozempic Price for One-month Supply
The pricing landscape for Ozempic varies considerably across countries, reflecting diverse market dynamics and healthcare systems. The U.S. stands out with a price of $936, which is significantly higher than the average price of $114 across all other listed countries. It's over five times the cost of the drug in Japan, priced at $169, the country with the second highest price.
This table presents the pricing data for a one-month supply of Ozempic in various countries:
| Countries | Prices |
|---|---|
| US | $936.00 |
| Japan | $169.00 |
| Canada | $147.00 |
| Switzerland | $144.00 |
| Germany | $103.00 |
| Netherlands | $103.00 |
| Sweden | $96.00 |
| United Kingdom | $93.00 |
| Australia | $87.00 |
| France | $83.00 |
Source: KFF analysis
Novo Nordisk Stock Price
In September 2023, Novo Nordisk (NVO) shares achieved a record peak, trading at $199.05 with a market capitalization of $335 billion. This represents a remarkable 340% appreciation since the introduction of Ozempic in December 2017.
The table below provides a comprehensive overview of the stock market data in USD for Novo Nordisk (NVO) since 2010:
| Quarters | Prices |
|---|---|
| Q1-2010 | $13.41 |
| Q1-2011 | $23.99 |
| Q1-2012 | $24.44 |
| Q1-2013 | $34.84 |
| Q1-2014 | $40.74 |
| Q1-2015 | $44.64 |
| Q1-2016 | $53.95 |
| Q1-2017 | $35.30 |
| Q1-2018 | $52.70 |
| Q1-2019 | $49.08 |
| Q1-2020 | $61.09 |
| Q1-2021 | $72.10 |
| Q1-2022 | $105.89 |
| Q1-2023 | $143.80 |
Source: NASDAQ
Ozempic Mainstream Interest
The digital landscape has been full of chatter about Ozempic, revealing a staggering uptick in its mainstream attention. Across internet platforms, from search engine inquiries to TikTok videos, the pharmaceutical narrative around Ozempic has evolved rapidly in just a few years.
Ozempic News Articles
News mentions of Ozempic have experienced a massive surge over the past year, with the highest peak in coverage in August 2023, reaching a remarkable 27,542 articles across 6,860 outlets. Cumulatively, there have been a total of 140,792 articles and 30,309 outlets mentioning Ozempic.
Here’s a list of all Ozempic news mentions between September 2022 and August 2023:
| Months | Articles | Outlets |
|---|---|---|
| September 2022 | 262 | 183 |
| October 2022 | 706 | 429 |
| November 2022 | 1468 | 820 |
| December 2022 | 2146 | 1512 |
| January 2023 | 6917 | 2566 |
| February 2023 | 7504 | 2684 |
| March 2023 | 16622 | 4975 |
| April 2023 | 15974 | 4586 |
| May 2023 | 16172 | 4416 |
| June 2023 | 26136 | 5988 |
| July 2023 | 19343 | 5679 |
| August 2023 | 27542 | 6860 |
Source: MuckRack
Ozempic Google Search Interest
Interest in the drug Ozempic on Google search has significantly increased over the past three years. Starting from August 2020, it reached its peak in August 2023, reflecting an astonishing 20-fold increase, a growth of 1900%.
Here's a breakdown of Google search interest for Ozempic from August 2020 to 2023:
| Months | Interest |
|---|---|
| August 2020 | 5% |
| December 2020 | 5% |
| March 2021 | 8% |
| June 2021 | 11% |
| September 2021 | 14% |
| December 2021 | 12% |
| March 2022 | 22% |
| June 2022 | 29% |
| September 2022 | 32% |
| December 2022 | 65% |
| March 2023 | 84% |
| June 2023 | 90% |
| August 2023 | 100% |
Source: Google
Ozempic Tiktok Videos
As a testament to the power of viral trends, Ozempic-themed videos on TikTok have skyrocketed in viewership over the past couple of years. Between January 2021 and October 2023, there has been a staggering 650x growth in monthly views for videos with the hashtag Ozempic, from 2 million views to 1.2 billion views, with 76% of all views in 2023.
Here’s a table showing the number of views per month for videos with #ozempic since 2021:
| Months | Views |
|---|---|
| January 2021 | 2 million |
| April 2021 | 4 million |
| July 2021 | 6 million |
| October 2021 | 15 million |
| January 2022 | 13 million |
| April 2022 | 20 million |
| July 2022 | 70 million |
| October 2022 | 96 million |
| January 2023 | 185 million |
| April 2023 | 239 million |
| July 2023 | 250 million |
| October 2023 | 400 million |
Source: TikTok
Ozempic Instagram Posts
The momentum behind Ozempic on Instagram has been nothing short of meteoric over the past few years. The cumulative post count surpassed the 110,000 mark by October 2023, reflecting a growth of over 650 times since January 2021. Interestingly, 82% of all posts were made in 2023.
Here's a table illustrating the number of Instagram posts per month featuring #ozempic from 2021 onward:
| Months | Posts |
|---|---|
| January 2021 | 169 |
| April 2021 | 338 |
| July 2021 | 508 |
| October 2021 | 1269 |
| January 2022 | 1100 |
| April 2022 | 1692 |
| July 2022 | 5923 |
| October 2022 | 8123 |
| January 2023 | 15654 |
| April 2023 | 20223 |
| July 2023 | 21154 |
| October 2023 | 33846 |
Source: Instagram
Ozempic Podcasts Episodes
As the podcast ecosystem has flourished and gained traction over the past decade, mentions of Ozempic in this medium have witnessed a remarkable surge. From 2020 to 2023, the number of podcast episodes mentioning Ozempic witnessed an impressive 2800% increase, growing from 109 to 3,200 episodes, with 1,778 new episodes in 2023 accounting for over 55% of this total.
Here's a breakdown of the number of podcast episodes mentioning Ozempic from 2020 to 2023:
| Years | Episodes |
|---|---|
| 2020 | 109 |
| 2021 | 365 |
| 2022 | 948 |
| 2023 | 1778 |
Source: ListenNotes
Weight Loss Drugs Market
The U.S. weight loss drug market is witnessing notable growth, with Ozempic emerging as a dominant player in both search interest and media mentions. This trend underscores the drug's increasing prominence in the sector, especially against the backdrop of the rising prevalence of obesity in the country.
Weight Loss Drugs U.S. Market Size
The U.S. market for weight loss drugs is on a significant upward trajectory over the coming years. By 2030, the cumulative market size is projected to reach $51 billion, marking a 3,000% increase from $2.4 billion in 2022.
The following data provides the projected cumulative market size for the weight loss drugs in the U.S:
| Years | Size |
|---|---|
| 2023 | $2.4 billion |
| 2024 | $11 billion |
| 2025 | $17 billion |
| 2026 | $23 billion |
| 2027 | $32 billion |
| 2028 | $38 billion |
| 2029 | $44 billion |
Source: Morgan Stanley
Weight Loss Drugs Google Search Interest
There’s one clear winner when it comes to Google searches for weight loss drugs: Ozempic. Over the past few years, it has consistently emerged as the dominant player, boasting a 300% higher search frequency than Wegovy, its closest competitor.
This table presents a quarterly breakdown of search interest in % for the leading weight loss drugs:
| Quarter | Ozempic | Wegovy | Mounjaro | Trulicity | Saxenda |
|---|---|---|---|---|---|
| Q3 2020 | 5 | 0 | 0 | 3.8 | 5.5 |
| Q4 2020 | 5.7 | 0 | 0 | 3.7 | 5.5 |
| Q1 2021 | 7.8 | 0 | 0 | 4 | 6.5 |
| Q2 2021 | 9.5 | 2.3 | 0 | 4.3 | 8 |
| Q3 2021 | 11.8 | 2.5 | 0 | 4.5 | 8.5 |
| Q4 2021 | 13.5 | 2.8 | 0 | 4.5 | 8.5 |
| Q1 2022 | 19.7 | 3.7 | 0 | 5.3 | 10.3 |
| Q2 2022 | 27.2 | 4.3 | 2 | 6 | 13.2 |
| Q3 2022 | 30.5 | 4 | 5.3 | 6.3 | 13 |
| Q4 2022 | 40.2 | 6.8 | 13 | 6.8 | 13.5 |
| Q1 2023 | 71 | 17.8 | 15.3 | 7.8 | 16 |
| Q2 2023 | 91 | 25 | 16.7 | 7.3 | 16.3 |
Source: Google
Weight Loss Drugs News Articles
The prescription weight loss drug sector has experienced strong media coverage, with Ozempic standing out with a notable 147,800 news article mentions. The combined mentions of Ozempic and Wegovy make up over 74% of the total mentions.
Here’s a list of the top weight loss drugs mentioned in news articles:
| Drugs | Mentions |
|---|---|
| Ozempic | 147800 |
| Wegovy | 120100 |
| Mounjaro | 45300 |
| Trulicity | 22600 |
| Saxenda | 16300 |
| Rybelsus | 13500 |
Source: MuckRack
Obesity in the U.S.
The global prevalence of obesity is strikingly high, with developed countries such as the United States at the forefront with a 34% obesity rate in 2022, highlighting a promising market for weight loss drugs like Ozempic. In contrast, European nations have an average obesity rate of just 17%, which is 50% lower than the U.S.
As we navigate the pressing issue of obesity, the table below offers a concise overview of its distribution among key countries:
| Countries | Prevalence |
|---|---|
| United States | 34% |
| United Kingdom | 26% |
| Canada | 22% |
| Australia | 20% |
| Germany | 17% |
| Austria | 17% |
| Belgium | 16% |
| Sweden | 15% |
| France | 14% |
| Netherlands | 14% |
| Switzerland | 11% |
Source: KFF analysis
That concludes the most comprehensive list of Ozempic statistics currently available on the market. If you use any information from this report, it is appreciated that you link back to this page. Thank you!